Venetoclax for unfit AML: real-world outcomes of standard and azole-adjusted dosing in Brazilian public and private care. // Blood Global Hematology. – URL: https://www.sciencedirect.com/science/article/pii/S3050565826000375?dgcid=rss_sd_all
Venetoclax for unfit AML: real-world outcomes of standard and azole-adjusted dosing in Brazilian public and private care. Blood Global Hematology. https://www.sciencedirect.com/science/article/pii/S3050565826000375?dgcid=rss_sd_all
“Venetoclax for unfit AML: real-world outcomes of standard and azole-adjusted dosing in Brazilian public and private care.” Blood Global Hematology.
@article{article99781,
title = {Venetoclax for unfit AML: real-world outcomes of standard and azole-adjusted dosing in Brazilian public and private care},
journal = {Blood Global Hematology},
url = {https://www.sciencedirect.com/science/article/pii/S3050565826000375?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez